PortfoliosLab logoPortfoliosLab logo
FOX vs. ABT
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

FOX vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fox Corporation (FOX) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

FOX vs. ABT - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
FOX
Fox Corporation
-17.78%43.41%68.25%-1.22%-15.80%20.19%-19.41%-5.89%
ABT
Abbott Laboratories
-17.64%12.87%4.81%2.26%-20.68%30.53%28.04%11.79%

Fundamentals

Market Cap

FOX:

$23.42B

ABT:

$179.36B

EPS

FOX:

$4.19

ABT:

$3.73

PE Ratio

FOX:

12.66

ABT:

27.52

PEG Ratio

FOX:

0.82

ABT:

1.72

PS Ratio

FOX:

1.44

ABT:

4.05

PB Ratio

FOX:

2.14

ABT:

3.44

Total Revenue (TTM)

FOX:

$16.58B

ABT:

$44.33B

Gross Profit (TTM)

FOX:

$4.29B

ABT:

$24.61B

EBITDA (TTM)

FOX:

$2.72B

ABT:

$11.33B

Returns By Period

The year-to-date returns for both investments are quite close, with FOX having a -17.78% return and ABT slightly higher at -17.64%.


FOX

1D
-1.26%
1M
3.20%
YTD
-17.78%
6M
-6.82%
1Y
1.79%
3Y*
20.90%
5Y*
10.23%
10Y*

ABT

1D
0.78%
1M
-11.76%
YTD
-17.64%
6M
-22.62%
1Y
-21.15%
3Y*
2.45%
5Y*
-1.11%
10Y*
11.37%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FOX vs. ABT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FOX
FOX Risk / Return Rank: 4343
Overall Rank
FOX Sharpe Ratio Rank: 4444
Sharpe Ratio Rank
FOX Sortino Ratio Rank: 3838
Sortino Ratio Rank
FOX Omega Ratio Rank: 3737
Omega Ratio Rank
FOX Calmar Ratio Rank: 4848
Calmar Ratio Rank
FOX Martin Ratio Rank: 5050
Martin Ratio Rank

ABT
ABT Risk / Return Rank: 88
Overall Rank
ABT Sharpe Ratio Rank: 66
Sharpe Ratio Rank
ABT Sortino Ratio Rank: 1010
Sortino Ratio Rank
ABT Omega Ratio Rank: 99
Omega Ratio Rank
ABT Calmar Ratio Rank: 1313
Calmar Ratio Rank
ABT Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FOX vs. ABT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fox Corporation (FOX) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FOXABTDifference

Sharpe ratio

Return per unit of total volatility

0.06

-0.92

+0.98

Sortino ratio

Return per unit of downside risk

0.30

-1.12

+1.42

Omega ratio

Gain probability vs. loss probability

1.04

0.84

+0.20

Calmar ratio

Return relative to maximum drawdown

0.23

-0.80

+1.03

Martin ratio

Return relative to average drawdown

0.61

-2.02

+2.62

FOX vs. ABT - Sharpe Ratio Comparison

The current FOX Sharpe Ratio is 0.06, which is higher than the ABT Sharpe Ratio of -0.92. The chart below compares the historical Sharpe Ratios of FOX and ABT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


FOXABTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.06

-0.92

+0.98

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.40

-0.05

+0.45

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.48

Sharpe Ratio (All Time)

Calculated using the full available price history

0.19

0.41

-0.22

Correlation

The correlation between FOX and ABT is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

FOX vs. ABT - Dividend Comparison

FOX's dividend yield for the trailing twelve months is around 1.05%, less than ABT's 2.34% yield.


TTM20252024202320222021202020192018201720162015
FOX
Fox Corporation
1.05%0.85%1.16%1.84%1.72%1.37%1.59%1.26%0.00%0.00%0.00%0.00%
ABT
Abbott Laboratories
2.34%1.88%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%

Drawdowns

FOX vs. ABT - Drawdown Comparison

The maximum FOX drawdown since its inception was -50.70%, smaller than the maximum ABT drawdown of -55.57%. Use the drawdown chart below to compare losses from any high point for FOX and ABT.


Loading graphics...

Drawdown Indicators


FOXABTDifference

Max Drawdown

Largest peak-to-trough decline

-50.70%

-55.57%

+4.87%

Max Drawdown (1Y)

Largest decline over 1 year

-26.77%

-25.18%

-1.59%

Max Drawdown (5Y)

Largest decline over 5 years

-32.96%

-33.88%

+0.92%

Max Drawdown (10Y)

Largest decline over 10 years

-33.88%

Current Drawdown

Current decline from peak

-21.21%

-25.41%

+4.20%

Average Drawdown

Average peak-to-trough decline

-17.77%

-14.29%

-3.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.20%

9.94%

+0.26%

Volatility

FOX vs. ABT - Volatility Comparison

The current volatility for Fox Corporation (FOX) is 4.99%, while Abbott Laboratories (ABT) has a volatility of 5.95%. This indicates that FOX experiences smaller price fluctuations and is considered to be less risky than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


FOXABTDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.99%

5.95%

-0.96%

Volatility (6M)

Calculated over the trailing 6-month period

19.04%

16.83%

+2.21%

Volatility (1Y)

Calculated over the trailing 1-year period

30.84%

23.14%

+7.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.89%

21.98%

+3.91%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.20%

23.57%

+7.63%

Financials

FOX vs. ABT - Financials Comparison

This section allows you to compare key financial metrics between Fox Corporation and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
5.18B
11.46B
(FOX) Total Revenue
(ABT) Total Revenue
Values in USD except per share items

FOX vs. ABT - Profitability Comparison

The chart below illustrates the profitability comparison between Fox Corporation and Abbott Laboratories over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
57.1%
Portfolio components
FOX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Fox Corporation reported a gross profit of 0.00 and revenue of 5.18B. Therefore, the gross margin over that period was 0.0%.

ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a gross profit of 6.54B and revenue of 11.46B. Therefore, the gross margin over that period was 57.1%.

FOX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Fox Corporation reported an operating income of 0.00 and revenue of 5.18B, resulting in an operating margin of 0.0%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported an operating income of 2.25B and revenue of 11.46B, resulting in an operating margin of 19.6%.

FOX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Fox Corporation reported a net income of 229.00M and revenue of 5.18B, resulting in a net margin of 4.4%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a net income of 1.78B and revenue of 11.46B, resulting in a net margin of 15.5%.